உறுப்பினர் ஜேம்ஸ் வந்தவர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Targeted News Service
targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.
US Federal Labor Viewpoints – Week Of July 19, 2021 - Employment and HR
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
ARPA Updates, Federal Contractor Min Wage, Welfare Reform and More
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
House Bill Would Create Long-Awaited Software and Data Roles at Federal Agencies Vertigo3d/iStock.com
email
The proposal would create new positions, including software development, software engineering and data scientists.
The federal government would finally be able to hire specifically for “software development,” “software engineering,” “data management,” and “knowledge management” positions under new legislation before the House.
Over multiple administrations, the federal government has tried to get better at hiring and retaining tech-savvy employees but continues to meet challenges, including the lack of specific job roles for positions that are critical to creating a digitally-driven government.
The Federal Career Opportunities in Computer Science Work Act looks to remedy that for four such positions. The bill introduced by Reps. Jay Obernolte, R-Calif., and Peter Welch, D-Vt. would give the Office of Personnel Management 270 days to es
email article
House lawmakers on both sides of the aisle pummeled AbbVie CEO Richard Gonzalez for raising the price of two widely used drugs and for the company s legally questionable tactics to head off competition from biosimilars, despite pulling in healthy profits.
Much of Tuesday s House Committee on Oversight and Reform hearing centered around two issues: the risks and benefits of Medicare price negotiation and potential abuse of the patent system.
Committee Chairwoman Carolyn Maloney (D-N.Y.) charged that Gonzalez and other AbbVie executives were actively targeting the U.S. for price increases while lowering prices in other countries.
AbbVie charges $77,000 for a year s supply of adalimumab (Humira), which is 470% more than what it charged when the drug was first launched in 2003. A single syringe of the tumor necrosis factor (TNF) blocking agent costs over $1,000 more in the U.S. compared to some other countries, including Canada, Japan, Korea, and the U.K.